2025-11-25T10:23:03-05:00 2025-06-30 222212404 BARATZ & ASSOCIATES PA 4B EVES DR STE 100 MARLTON NJ 08053 990 2024-07-01 232745935 SBARRO HEALTH RESEARCH ORGANIZATION SBAR 2152040304 BIO-LIFE SCIENCES BLDG 1900 N 12TH PHILADELPHIA PA 19122 ANTONIO GIORDANO PRESIDENT 2152040304 2025-11-25 true true RYAN DOWDELL CPA P01747196 8569855688 2025-11-25 2024 2025-03-06 01:10:19Z ANTONIO GIORDANO BIO-LIFE SCIENCES BLDG 1900 N 12TH PHILADELPHIA PA 19122 2432684 false X WWW.SHRO.ORG X 1993 PA GENETIC RESEARCH TO HELP CURE AND DIAGNOSE CANCER AND OTHER SERIOUS DISEASES 7 7 1 0 2198245 2183243 0 28420 47339 39976 79619 2266641 2310201 0 0 133574 224371 0 0 1665048 2104420 1798622 2328791 468019 -18590 2895944 3223201 763691 962238 2132253 2260963 GENETIC RESEARCH TO HELP CURE AND DIAGNOSE CANCER AND OTHER SERIOUS DISEASES false false 1949721 THE ORGANIZATION CONDUCTED RESEARCH THAT LEAD TO THE PUBLICATION OF SCIENTIFIC PAPERS IN THE FIELD OF CANCER RESEARCH 1949721 true true false false false false false false false false false false false true true true true false false false false false false false true false false false false false false false false false false false false false false false false false false false false false false true 10 0 1 true false false false false false false false false false false false false false false X 7 7 false false false false false false false true true false false true true true true true true true true false PA X X JAMES VINCENZO 2152040304 1900 N 12TH STREET PHILADELPIA PA 19122 ANTONIO GIORDANO PRESIDENT 40.00 X X 0 0 0 MARIO SBARRO BOARD MEMBER 1.00 X 0 0 0 ANDREW DOUGLAS BOARD MEMBER 1.00 X 0 0 0 DIRK SIMPSON BOARD MEMBER 1.00 X 0 0 0 LUCIANO DOLGETTA BOARD MEMBER 1.00 X 0 0 0 GENNARO SBARRO BOARD MEMBER 1.00 X 0 0 0 JAMES VINCENZO CFO 20.00 X 44000 0 0 GRACE AUTERI SECRETARY 20.00 X X 48875 0 0 GIANCARLO ARRA VICE PRESIDE 40.00 X X 0 0 0 92875 false false false 1850000 333243 2183243 47339 47339 202102 122483 79619 2310201 47339 X 92875 48875 44000 40400 40400 84632 84632 6464 6464 915746 839939 75807 35839 35839 42362 42362 122314 73388 48926 11056 5888 5168 SUPPLIES 511191 511191 PROJECT COSTS 335641 268513 67128 EQUIPMENT 117295 117295 PHONE AND INTERNET 12976 12976 2328791 1949721 379070 0 618771 1764716 108114 25000 1924322 1200388 244737 233097 2895944 3223201 518954 729141 244737 233097 763691 962238 X 2132253 2260963 2132253 2260963 2895944 3223201 X -18590 147300 X false true X true false X 1499819 1530502 1812601 2198245 2183243 9224410 1499819 1530502 1812601 2198245 2183243 9224410 9224410 9951 33221 31967 28420 47339 150898 9375308 202102 0.98390 0.98330 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RIGHT OF USE ASSET 233097 233097 LEASE LIABILITY 233097 233097 X 2579984 147300 122483 269783 2310201 2310201 2451274 122483 122483 2328791 2328791 SCHEDULE D, PAGE 3, PART X NO PROVISIONS ARE MADE FOR FEDERAL AND STATE INCOME TAXES. THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAXES PURSUANT TO SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. FASB ASC 740-10-65-1 REQUIRES FINANCIAL STATEMENT RECOGNITION OF THE IMPACT OF A TAX POSITION, IF THAT POSITION IS MORE THAN LIKELY THAN NOT TO BE SUSTAINED ON EXAMINATION, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE BENEFIT IS CALCULATED AS THE LARGEST AMOUNT THAT IS MORE THAN 50 PERCENT LIKELY TO BE REALIZED UPON RESOLUTION OF THE BENEFIT. THE ORGANIZATION HAS EVALUATED ITS TAX POSITIONS AND BELIEVES ALL COULD BE SUSTAINED UPON EXAMINATION. WITH FEW EXCEPTIONS, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY FEDERAL AUTHORITIES FOR YEARS BEFORE 2022. SCHEDULE D, PAGE 4, PART XI, LINE 2D FUNDRAISING EXPENSE 122,483 SCHEDULE D, PAGE 4, PART XII, LINE 2D FUNDRAISING EXPENSE 122,483 FUNDRAISING 202102 202102 122483 202102 202102 122483 122483 79619 FORM 990, PAGE 6, PART VI, LINE 11B FORM 990 IS DISTRIBUTED FOR REVIEW AND PREPARER IS GIVEN FEEDBACK. THEN THE FINAL DRAFT IS APPROVED. FORM 990, PAGE 6, PART VI, LINE 12C THE POLICY IS MONITORED BY THE ORGANIZATION'S DIRECTORS AND LEGAL COUNCIL. FORM 990, PAGE 6, PART VI, LINE 15A THE EXECUTIVE DIRECTOR'S COMPENSATION IS PAID IN ACCORDANCE WITH NIH APPROVED COMPENSATION CRITERIA FORM 990, PAGE 6, PART VI, LINE 15B THE COMPENSATION OF OFFICERS AND KEY EMPLOYEES IS PAID IN ACCORDANCE WITH NIH APPROVED COMPENSATION CRITERIA FORM 990, PAGE 6, PART VI, LINE 19 AVAILABLE VIA ANOTHERS WEBSITE OR UPON REQUEST FORM 990, PART IX, LINE 11G RESEARCHERS 663,057 0 0 PROFESSIONAL FEES 176,882 75,807 0 TOTAL 839,939 75,807 0 FORM 990, PART XI, LINE 9 FUNDRAISING EXPENSE 122,483 FUNDRAISING EXPENSE -122,483